Olivier Bogillot
Präsident bei PROVENTION BIO, INC.
Aktive Positionen von Olivier Bogillot
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PROVENTION BIO, INC. | Direktor/Vorstandsmitglied | 27.04.2023 | - |
Präsident | 27.04.2023 | - | |
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Vorstandsvorsitzender | - | - |
Vorsitzender | - | - | |
Sanofi Pasteur Merieux SAS
Sanofi Pasteur Merieux SAS Financial ConglomeratesFinance Part of Sanofi, Sanofi Pasteur Merieux SAS is a French healthcare company that offers a wide range of medicines, vaccines, and healthcare products in various therapeutic areas. The company is based in Paris, France. Sanofi France is committed to promoting diversity and inclusion by supporting young people in employment, integrating the LGBT+ community, people with disabilities, and promoting gender equality. | Vorsitzender | 01.03.2020 | - |
Karriereverlauf von Olivier Bogillot
Statistik
International
Frankreich | 3 |
Vereinigte Staaten | 2 |
Operativ
Chairman | 2 |
Chief Executive Officer | 1 |
Director/Board Member | 1 |
Sektoral
Distribution Services | 2 |
Finance | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Distribution Services |
Sanofi Pasteur Merieux SAS
Sanofi Pasteur Merieux SAS Financial ConglomeratesFinance Part of Sanofi, Sanofi Pasteur Merieux SAS is a French healthcare company that offers a wide range of medicines, vaccines, and healthcare products in various therapeutic areas. The company is based in Paris, France. Sanofi France is committed to promoting diversity and inclusion by supporting young people in employment, integrating the LGBT+ community, people with disabilities, and promoting gender equality. | Finance |
Provention Bio, Inc.
Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D), PRV-015 for the treatment of gluten-free diet non-responding celiac disease, PRV-6527 for Crohn’s disease, PRV-3279 for the treatment of lupus, and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Red Bank, NJ. | Health Technology |
- Börse
- Insiders
- Olivier Bogillot
- Erfahrung